The current P/E ratio for VCEL can't be determined, as the TTM EPS is $0. The last recorded PE ratio for Vericel was 4880.0 in September 2021.
The average historical PE ratio of Vericel for the last four years is 1305.03. In the past four years, VCEL's PE ratio reached its highest point in the Sep 2021 quarter at 4,880, when the stock price was $48.8 and the EPS was $0.01. The lowest point was recorded in the Jun 2021 quarter, when it reached 262.5 with a price of $52.5 and an EPS of $0.2.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | 514.67 | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
RPRX Royalty Pharma plc | 15.23 | $16.29B |
NEOG Neogen Corp | 677 | $2.93B |
NURO NeuroMetrix Inc | N/A | $8.05M |
VCEL Vericel Corp | N/A | $2.35B |
The current price to earnings ratio for VCEL can't be calculated, as its EPS is $0.
The average PE ratio for VCEL stock over the past 5 years is 1305.03.
Over the last four years, the quarterly PE ratio reached a historic high of 4,880 in the Sep 2021 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.